Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonetta Buglioni

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Plos One|February 11, 2017
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patientsIrene Terrenato, Valerio D'Alicandro, Beatrice Casini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapyClaudio Botti, Simonetta Buglioni, Maria Benevolo, et al.
Journal of Cellular Physiology|December 29, 2004
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancerMarcella Mottolese, Edit A Nádasi, Claudio Botti, et al.
Cancers|April 23, 2022
Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative ReviewFilippo Tommaso Gallina, Luca Bertolaccini, Daniele Forcella, et al.
Oncogenesis|February 24, 2018
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcomaMarta Di Martile, Marianna Desideri, Maria Grazia Tupone, et al.
Journal of Biomedical Informatics|May 20, 2023
Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparednessMartina Betti, Chiara Maria Salzano, Alice Massacci, et al.
Breast Cancer Research : BCR|September 6, 2008
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyFlavia Novelli, Michele Milella, Elisa Melucci, et al.
Molecular Cancer Research : MCR|January 27, 2022
HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer ProgressionMicol Di Segni, Ilaria Virdia, Alessandra Verdina, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient careAlessandra Fabi, Anna Di Benedetto, Giulio Metro, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Plos One|February 11, 2017
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patientsIrene Terrenato, Valerio D'Alicandro, Beatrice Casini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapyClaudio Botti, Simonetta Buglioni, Maria Benevolo, et al.
Journal of Cellular Physiology|December 29, 2004
Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancerMarcella Mottolese, Edit A Nádasi, Claudio Botti, et al.
Cancers|April 23, 2022
Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative ReviewFilippo Tommaso Gallina, Luca Bertolaccini, Daniele Forcella, et al.
Oncogenesis|February 24, 2018
Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcomaMarta Di Martile, Marianna Desideri, Maria Grazia Tupone, et al.
Journal of Biomedical Informatics|May 20, 2023
Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparednessMartina Betti, Chiara Maria Salzano, Alice Massacci, et al.
Breast Cancer Research : BCR|September 6, 2008
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyFlavia Novelli, Michele Milella, Elisa Melucci, et al.
Molecular Cancer Research : MCR|January 27, 2022
HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer ProgressionMicol Di Segni, Ilaria Virdia, Alessandra Verdina, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient careAlessandra Fabi, Anna Di Benedetto, Giulio Metro, et al.
Pageof 9